Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions.


Autoria(s): Cuisset T.; Mudra H.; Muller O.; Vogt P.; Angelillo-Scherrer A.; Huber K.
Data(s)

2008

Identificador

http://serval.unil.ch/?id=serval:BIB_F375ACB8D8FD

isbn:1774-024X

pmid:19110780

Idioma(s)

en

Fonte

EuroIntervention, vol. 4, no. 2, pp. 183-186

Palavras-Chave #Angioplasty, Transluminal, Percutaneous Coronary; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Risk Factors; Thrombosis
Tipo

info:eu-repo/semantics/review

article